Tip:
Highlight text to annotate it
X
CAMERA.FIRST HERE'S ERIKA
IN HEALTH NEWS - ONE OF THE
LEADING RESEARCHERS IN BREAST
CANCER IS NOW AT SMILOW CANCER
HOSPITAL AT YALE-NEW HAVEN.
NEWS 8 MEDICAL REPORTER
JOCELYN MAMINTA IS HERE TO
IMPACT BREAST CANCER PATIENTS.
JOC? SONIA-DARREN --
DR. LAJOSPUSZTAI IS HIGHLY
REGARDED AMONG HIS PEERS FOR
HIS WORK IN BREAST CANCER.
THROUGH CLINICAL TRIALS --
HE HAS HELPED DEVELOP TARGETED
THERAPIES -- TO HELP WOMEN
SURVIVE BREAST CANCER.
3
THERE ARE NEARLY 3 MILLION
UNITED STATES -- PROGRESS
INDEED -- STILL ABOUT 40
THOUSAND WILL DIE OF BREAST
CANCER THIS YEAR. TO IMPROVE
THOSE NUMBERS -- WELL KNOWN
REASERCHER DR. LAJOS PUZSTAI
SAYS -- IT COMES DOWN TO
IMPROVED THERAPEUTIC
STRATEGIES AND MORE EFFECTIVE
THESE DRUGS AND MOVE THEM INTO
THE EARLIEST STAGE SETTING
WHERE WE CAN ACTUALLY MOVE
CURE RATES." DR.
PUZSTAI IS DEVELOPING RESEARCH
AND CLINICAL TRIALS AT SMILOW
CANCER HOSPITAL AT YALE-NEW
HAVEN. SIX STUDIES ARE
CURRENTLY OPEN FOR BREAST
CANCER PATIENTS. THE MOST
EXCITING -- A DRUG FOR ADVANCE
STAGE BREAST CANCER -- THAT
TARGETS THE SURFACE OF IMMUNE
CELLS IN A TUMOR -- BOOSTING
THE IMMUNE SYSTEM." "THIS
MOLECULE CAN INCREASE THE
PRESENCE AND ACTIVITY OF
IMMUNE CELLS IN THE CANCER AND
SHRINK MOLECULAR ACTIVITIES IN
SOME CONCERNS WHICH HAVE BEEN
VERY DIFFICULT TO TREAT."
IT'S ALL PART OF A NOVEL
APPROACH OF SELECTING PATIENTS
FOR STUDIES - BASED ON THE
MOLECULAR MAKEUP OF THE
CANCER. "BRING ALL
THESE DRUGS TOGETHER IN THE
PRE-OPERATIVE TREATMENT AND WE
HOPE WE AN ACTUALLY ERADICATE
THE CANCER BEFORE IT COMES TO
HOPE WE AN ACTUALLY ERADICATE
DID. I'M SO HAPPY I HAVE
NOTHING." MELINDA MARGITAS
WAS DIAGNOSED WITH STAGE 2
BREAST CANCER 2 AND A HALF
YEARS AGO. AFTER TAKING
PART IN A PHASE 3 STUDY -- SHE
IS NOW CANCER FREE. "I WANT
EVERYTHING TO CURE THE WOMEN
WHO HAVE THE CANCER. THIS IS
A MEDICATION GIVEN TO ME AND
I'M SO HAPPY I DID BECAUSE IT
WORKED FOR ME, IT WORKED."
MODERN SCIENCE -- AT ITS
BEST.
OTHER BREAST CANCER STUDIES
AT SMILOW -- INCLUDE A DRUG --
TREATMENT -- AIMED AT
IMPROVING CURE RATES IN THE
EARLY CURABLE STAGE. FOR MORE
INFORMATION - LOG ONTO WTNH
DOT COM.